We are live on ! Find out more
MBE

Michael B. Elefante Portfolio holdings

AUM $91.5M Turnover 27.89%
1-Year Est. Return 13.24%
This Fund
S&P 500
This Quarter Est. Return
+1.4%
1 Year Est. Return
+13.24%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$184M
AUM Growth
–
Cap. Flow
+$185M
Cap. Flow %
100.56%
Top 10 Hldgs %
35.73%
Holding
108
New
108
Increased
–
Reduced
–
Closed
–
Avg Time Held
0 years
Top 10 Avg Time Held
0 years
Top 20 Avg Time Held
0 years

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$7.69M
2
CVS icon
CVS Health
CVS
+$7.64M
3
EMR icon
Emerson Electric
EMR
+$6.95M
4
NVS icon
Novartis
NVS
+$6.93M
5
PG icon
Procter & Gamble
PG
+$6.82M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 25.97%
2 Technology 20.49%
3 Industrials 17.98%
4 Energy 10.31%
5 Consumer Staples 8.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
LH icon
26
Labcorp
LH
$25.7B
$2.38M 1.29%
+27,610
New +$2.29M
2013 Q2
0 quarters
ROK icon
27
Rockwell Automation
ROK
$47B
$2.33M 1.27%
+28,030
New +$2.42M
2013 Q2
0 quarters
ABB
28
DELISTED
ABB Ltd
ABB
$2.33M 1.26%
+107,575
New +$2.38M
2013 Q2
0 quarters
HD icon
29
Home Depot
HD
$295B
$2.23M 1.21%
+28,733
New +$2.16M
2013 Q2
0 quarters
CSCO icon
30
Cisco
CSCO
$448B
$2.2M 1.19%
+90,208
New +$2.03M
2013 Q2
0 quarters
JCI icon
31
Johnson Controls International
JCI
$92.3B
$2.19M 1.19%
+58,413
New +$2.18M
2013 Q2
0 quarters
NXPI icon
32
NXP Semiconductors
NXPI
$55.7B
$2.16M 1.17%
+69,575
New +$2.04M
2013 Q2
0 quarters
HP icon
33
Helmerich & Payne
HP
$3.86B
$2.05M 1.11%
+32,880
New +$2.02M
2013 Q2
0 quarters
FISV icon
34
Fiserv Inc
FISV
$24.5B
$2.03M 1.1%
+92,840
New +$2.04M
2013 Q2
0 quarters
ILMN icon
35
Illumina
ILMN
$41B
$1.95M 1.06%
+26,779
New +$1.71M
2013 Q2
0 quarters
IPGP icon
36
IPG Photonics
IPGP
$3.13B
$1.9M 1.03%
+31,230
New +$1.91M
2013 Q2
0 quarters
SPY icon
37
State Street SPDR S&P 500 ETF Trust
SPY
$813B
$1.54M 0.84%
+9,625
New +$1.55M
2013 Q2
0 quarters
ABT icon
38
Abbott
ABT
$178B
$1.3M 0.71%
+37,350
New +$1.37M
2013 Q2
0 quarters
GIS icon
39
General Mills
GIS
$17.2B
$1.21M 0.66%
+25,010
New +$1.23M
2013 Q2
0 quarters
GE icon
40
GE Aerospace
GE
$319B
$1.04M 0.56%
+9,328
New +$1.03M
2013 Q2
0 quarters
HON icon
41
Honeywell
HON
$65.8B
$1M 0.55%
+14,100
New +$972K
2013 Q2
0 quarters
MRK icon
42
Merck
MRK
$364B
$933K 0.51%
+21,054
New +$940K
2013 Q2
0 quarters
DD icon
43
DELISTED
Du Pont De Nemours E I
DD
$731K 0.4%
+14,678
New +$741K
2013 Q2
0 quarters
IBM icon
44
IBM
IBM
$215B
$703K 0.38%
+3,848
New +$749K
2013 Q2
0 quarters
GLW icon
45
Corning
GLW
$121B
$639K 0.35%
+44,880
New +$653K
2013 Q2
0 quarters
BRK.B icon
46
Berkshire Hathaway Class B
BRK.B
$1.13T
$605K 0.33%
+5,400
New +$594K
2013 Q2
0 quarters
ABBV icon
47
AbbVie
ABBV
$501B
$579K 0.31%
+14,000
New +$612K
2013 Q2
0 quarters
WMT icon
48
Walmart Inc
WMT
$922B
$564K 0.31%
+22,695
New +$582K
2013 Q2
0 quarters
ALNY icon
49
Alnylam Pharmaceuticals
ALNY
$30B
$518K 0.28%
+16,730
New +$445K
2013 Q2
0 quarters
NVO icon
50
Novo Nordisk
NVO
$168B
$504K 0.27%
+32,500
New +$541K
2013 Q2
0 quarters
1
2
3 4

Similar funds

AEPI
AH Equity Partners II Menlo Park, California $91.5M AUM
CC
Columbia Capital Fullerton, California $91.6M AUM 27.93% 1-Year Est. Return
TM
TigerShark Management New York $98.9M AUM 11.4% 1-Year Est. Return
VNB
Valley National Bancorp New York $81.9M AUM 5.36% 1-Year Est. Return
ECP
Empirical Capital Partners Ringgold, Georgia $101M AUM
WIL
Winifred I. Li $106M AUM 11.93% 1-Year Est. Return
RCM
Raptor Capital Management Boston, Massachusetts $73.2M AUM 23.77% 1-Year Est. Return
ZTNA
Zions Trust National Association Salt Lake City, Utah $69.4M AUM 2.73% 1-Year Est. Return

Michael B. Elefante's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Michael B. Elefante, which disclosed 108 positions worth $184M. Its ten largest holdings account for 36% of the portfolio.

Its largest position is Johnson & Johnson: 90,570 shares worth $7.78M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, followed by Technology and Industrials.

  • Michael B. Elefante's largest Q2 2013 buy was Johnson & Johnson: 90,570 shares worth $7.78M.
  • Michael B. Elefante's ten largest holdings make up 36% of its $184M portfolio in Q2 2013.
  • Michael B. Elefante disclosed 108 positions in Q2 2013, its first 13F filing on record.

Based on Michael B. Elefante's 13F filing for Q2 2013, filed 19 Aug 2013.